Israeli researchers develop promising new blood cancer treatment
The technology has now been licensed to Immix BioPharma for further development and commercialization.
Source: jpost.com
Stay updated with breaking news from Ortal Harush. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The technology has now been licensed to Immix BioPharma for further development and commercialization.
/PRNewswire/ -- Hadasit, the Innovation Engine of Hadassah Medical Organization and BIRAD, the Commercialization arm of Bar-Ilan University announced today...